Company / R&D Expense
TELA Bio, Inc. R&D Expense History
FY2019-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest R&D Expense
$9.6M
FY2025
5-year range
$4.2M / $9.6M
FY2021-FY2025
Trend
+7.6%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
R&D Expense has increased for 4 consecutive years, from $4M in FY2021 to $10M in FY2025.
Based on SEC 10-K filings.
$10M in FY2025 with a 5-year CAGR of +17.3%.
Improved from $7M to $10M over the past 2 years.
R&D Expense over time
Growth rates
- 3-Year CAGR
- +31.2%
- 5-Year CAGR
- +17.3%
- 10-Year CAGR
- -
Key checks
Key Insights
- TELA Bio, Inc.'s r&d expense has grown for 4 consecutive years.
- 5-year CAGR of +17.3%, indicating consistent growth.
- In FY2025, r&d expense increased 7.6% year-over-year.
- Lowest r&d expense in the period was in FY2021.
Company context
Key Data Points
- Altman Z-Score -0.23 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | R&D ExpenseValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $9.6M | +7.6% |
| FY2024 | $8.9M | +32.5% |
| FY2023 | $6.7M | +58.5% |
| FY2022 | $4.3M | +2.5% |
| FY2021 | $4.2M | -4.3% |
| FY2020 | $4.3M | -25.0% |
| FY2019 | $5.8M | - |
As of FY2025 · SEC 10-K · Updated Jun 28, 2026